Zerumbone attenuates TGF-β1-mediated epithelial-mesenchymal transition via upregulated E-cadherin expression and downregulated Smad2 signalling pathways in non-small cell lung cancer (A549) cells

Journal of Functional Foods

Volumn 18, Issue , 2015, Pages 58-72

  Hseu, You Cheng ^a,b   Huang, Yu Chi ^a   Korivi, Mallikarjuna ^a   Wu, Jia Jiuan ^a   Way, Tzong Der ^a   Ou, Ting Tsz ^a   Chiu, Li Wen ^a   Lee, Chuan Chen ^b   Lin, Meng Liang ^a   Yang, Hsin Ling ^a  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b ASIA UNIVERSITY   (Taiwan)

Author keywords

E cadherin; EMT; Metastasis; Smad2; Wound healing; Zerumbone

Indexed keywords

EID: 84942521960     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2015.06.058     Document Type: Article

References (41)

1. Arias A.M. Epithelial mesenchymal interactions in cancer and development. Cell 2001, 105:425-431.
2. Bhowmick N.A., Ghiassi M., Bakin A., Aakre M., Lundquist C.A., Engel M.E., Arteaga C.L., Moses H.L. Transforming growth factor-beta1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism. Molecular Biology of the Cell 2001, 12(1):27-36.
3. Bjorklund M., Koivunen E. Gelatinase-mediated migration and invasion of cancer cells. Biochimica et Biophysica Acta 2005, 1755(1):37-69.
4. Chu Q., Ling M.T., Feng H., Cheung H.W., Tsao S.W., Wang X., Wong Y.C. A novel anticancer effect of garlic derivatives: Inhibition of cancer cell invasion through restoration of E-cadherin expression. Carcinogenesis 2006, 27(11):2180-2189.
5. Derynck R., Zhang Y.E. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 2003, 425(6958):577-584.
6. Embuscado M.E. Spices and herbs: Natural sources of antioxidants - A mini review. Journal of Functional Foods 2015, in press. 10.1016/j.jff.2015.03.005.
7. Esposito L., Conti D., Ailavajhala R., Khalil N., Giordano A. Lung cancer: Are we up to the challenge?. Current Genomics 2010, 11(7):513-518.
8. Han J., Bae S.Y., Oh S.J., Lee J., Lee J.H., Lee H.C., Lee S.K., Kil W.H., Kim S.W., Nam S.J., Kim S., Lee J.E. Zerumbone suppresses IL-1beta-induced cell migration and invasion by inhibiting IL-8 and MMP-3 expression in human triple-negative breast cancer cells. Phytotherapy Research 2014, 28(11):1654-1660.
9. Hu Z., Zeng Q., Zhang B., Liu H., Wang W. Promotion of p53 expression and reactive oxidative stress production is involved in zerumbone-induced cisplatin sensitization of non-small cell lung cancer cells. Biochimie 2014, 107(Pt. B):257-262.
10. Ikushima H., Miyazono K. TGFbeta signalling: A complex web in cancer progression. Nature Reviews. Cancer 2010, 10(6):415-424.
11. Kapoor S. The rapidly emerging role of zerumbone in attenuating tumor growth in systemic malignancies. Molecular Nutrition and Food Research 2012, 56(10):1487.
12. Kasai H., Allen J.T., Mason R.M., Kamimura T., Zhang Z. TGF-beta1 induces human alveolar epithelial to mesenchymal cell transition (EMT). Respiratory Research 2005, 6:56.
13. Kim M., Miyamoto S., Yasui Y., Oyama T., Murakami A., Tanaka T. Zerumbone, a tropical ginger sesquiterpene, inhibits colon and lung carcinogenesis in mice. International Journal of Cancer 2009, 124(2):264-271.
14. Kudo Y., Kitajima S., Ogawa I., Hiraoka M., Sargolzaei S., Keikhaee M.R., Sato S., Miyauchi M., Takata T. Invasion and metastasis of oral cancer cells require methylation of E-cadherin and/or degradation of membranous beta-catenin. Clinical Cancer Research 2004, 10(16):5455-5463.
15. Levine B. Cell biology: Autophagy and cancer. Nature 2007, 446(7137):745-747.
16. Mallikarjuna K., Chetan P.S., Reddy K.S., Rajendra W. Ethanol toxicity: Rehabilitation of hepatic antioxidant defense system with dietary ginger. Fitoterapia 2008, 79(3):174-178.
17. Massague J., Blain S.W., Lo R.S. TGFbeta signaling in growth control, cancer, and heritable disorders. Cell 2000, 103(2):295-309.
18. Murakami A., Takahashi D., Kinoshita T., Koshimizu K., Kim H.W., Yoshihiro A., Nakamura Y., Jiwajinda S., Terao J., Ohigashi H. Zerumbone, a Southeast Asian ginger sesquiterpene, markedly suppresses free radical generation, proinflammatory protein production, and cancer cell proliferation accompanied by apoptosis: The alpha,beta-unsaturated carbonyl group is a prerequisite. Carcinogenesis 2002, 23(5):795-802.
19. Pankiv S., Clausen T.H., Lamark T., Brech A., Bruun J.A., Outzen H., Øvervatn A., Bjørkøy G., Johansen T. p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. The Journal of Biological Chemistry 2007, 282(33):24131-24145.
20. Peinado H., Portillo F., Cano A. Transcriptional regulation of cadherins during development and carcinogenesis. The International Journal of Developmental Biology 2004, 48(5-6):365-375.
21. Petersen M., Thorikay M., Deckers M., Van Dinther M., Grygielko E., Gellibert F., De Gouville A., Huet S., Ten Dijke P., Laping N. Oral administration of GW788388, an inhibitor of TGF-β type I and II receptor kinases, decreases renal fibrosis. Kidney International 2007, 73:705-715.
22. Prasannan R., Kalesh K.A., Shanmugam M.K., Nachiyappan A., Ramachandran L., Nguyen A.H., Kumar A.P., Lakshmanan M., Ahn K.S., Sethi G. Key cell signaling pathways modulated by zerumbone: Role in the prevention and treatment of cancer. Biochemical Pharmacology 2012, 84:1268-1276.
23. Rahman H.S., Rasedee A., How C.W., Abdul A.B., Zeenathul N.A., Othman H.H., Saeed M.I., Yeap S.K. Zerumbone-loaded nanostructured lipid carriers: Preparation, characterization, and antileukemic effect. International Journal of Nanomedicine 2013, 8:2769-2781.
24. Ranganathan P., Agrawal A., Bhushan R., Chavalmane A.K., Kalathur R.K., Takahashi T., Kondaiah P. Expression profiling of genes regulated by TGF-β: Differential regulation in normal and tumour cells. BMC Genomics 2007, 8:98.
25. Sadhu S.K., Khatun A., Ohtsuki T., Ishibashi M. First isolation of sesquiterpenes and flavonoids from Zingiber spectabile and identification of zerumbone as the major cell growth inhibitory component. Natural Product Research 2007, 21(14):1242-1247.
26. Scanlon C.S., Van Tubergen E.A., Inglehart R.C., D'Silva N.J. Biomarkers of epithelial-mesenchymal transition in squamous cell carcinoma. Journal of Dental Research 2013, 92(2):114-121.
27. Stoilova I., Krastanov A., Stoyanova A., Denev P., Gargova S. Antioxidant activity of a ginger extract (Zingiber officinale). Food Chemistry 2007, 102(3):764-770.
28. Sung B., Jhurani S., Ahn K.S., Mastuo Y., Yi T., Guha S., Liu M., Aggarwal B.B. Zerumbone down-regulates chemokine receptor CXCR4 expression leading to inhibition of CXCL12-induced invasion of breast and pancreatic tumor cells. Cancer Research 2008, 68(21):8938-8944.
29. Thiery J.P. Epithelial-mesenchymal transitions in tumour progression. Nature Reviews. Cancer 2002, 2(6):442-454.
30. Thiery J.P., Acloque H., Huang R.Y., Nieto M.A. Epithelial-mesenchymal transitions in development and disease. Cell 2009, 139(5):871-890.
31. Tsim S., O'Dowd C.A., Milroy R., Davidson S. Staging of non-small cell lung cancer (NSCLC): A review. Respiratory Medicine 2010, 104(12):1767-1774.
32. Wang T., Nelson R.A., Bogardus A., Grannis F.W. Five-year lung cancer survival: Which advanced stage nonsmall cell lung cancer patients attain long-term survival?. Cancer 2010, 116(6):1518-1525.
33. Willis B.C., Borok Z. TGF-beta-induced EMT: Mechanisms and implications for fibrotic lung disease. American Journal of Physiology. Lung Cellular and Molecular Physiology 2007, 293(3):L525-L534.
34. Yang J., Dai C., Liu Y. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition. Journal of the American Society of Nephrology 2005, 16(1):68-78.
35. Yang J., Weinberg R.A. Epithelial-mesenchymal transition: At the crossroads of development and tumor metastasis. Developmental Cell 2008, 14(6):818-829.
36. Yang T., Chen M., Sun T. Simvastatin attenuates TGF-β1-induced epithelial-mesenchymal transition in human alveolar epithelial cells. Cellular Physiology and Biochemistry: International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology 2013, 31:863-874.
37. Yob N.J., Jofrry S.M., Affandi M.M., Teh L.K., Salleh M.Z., Zakaria Z.A. Zingiber zerumbet (L.) Smith: A review of its ethnomedicinal, chemical, and pharmacological uses. Evidence-based Complementary and Alternative Medicine 2011, 2011:543216.
38. Yuki K., Yoshida Y., Inagaki R., Hiai H., Noda M. E-cadherin-downregulation and RECK-upregulation are coupled in the non-malignant epithelial cell line MCF10A but not in multiple carcinoma-derived cell lines. Scientific Reports 2014, 4:4568.
39. Zarogoulidis K., Zarogoulidis P., Darwiche K., Boutsikou E., Machairiotis N., Tsakiridis K., Katsikogiannis N., Kougioumtzi I., Karapantzos I., Huang H., Spyratos D. Treatment of non-small cell lung cancer (NSCLC). Journal of Thoracic Disease 2013, 5(Suppl. 4):S389-S396.
40. Zavadil J., Bottinger E.P. TGF-beta and epithelial-to-mesenchymal transitions. Oncogene 2005, 24(37):5764-5774.
41. Zhang Y.E. Non-Smad pathways in TGF-beta signaling. Cell Research 2009, 19(1):128-139.